Retinoids control the expression of c-erbB receptors in breast cancer cells

Biochem Biophys Res Commun. 1998 Oct 29;251(3):907-13. doi: 10.1006/bbrc.1998.9570.

Abstract

Nuclear retinoid and membrane c-erbB receptors participate in signal transduction systems that control mammary epithelial cell proliferation and differentiation. Recently, we demonstrated that c-erbB receptor activation stimulates retinoic acid receptor-alpha expression. We now report that retinoids reduce SK-BR-3 breast cancer cell growth by inhibiting the cell cycle and by inducing apoptosis. This is accompanied with reduced c-erbB expression as determined by FACS, Western, Northern, RT-PCR, and reporter assays. All-trans (ATRA) and 9-cis retinoic acid (9cRA) reduce c-erbB-1 protein to 50-100%, c-erbB-2 to 20-30%, and c-erbB-3 to 10-50% of control, depending on the concentration, respectively, without influencing the tyrosine phosphorylation status. Down-regulation of c-erbB-2 and -3 was seen at all levels analyzed, whereas c-erbB-1 mRNA remained unchanged. Retinoic acid-mediated down-regulation of growth and c-erbB-2 and -3 expression was also seen in MCF-7 cells. We conclude that retinoic acids are efficient repressors of c-erbB-2 and -3 gene expression, whereas c-erbB-1 is not markedly affected.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alitretinoin
  • Antineoplastic Agents / pharmacology*
  • Apoptosis
  • Breast Neoplasms / genetics*
  • Cell Cycle / drug effects
  • ErbB Receptors / biosynthesis
  • Gene Expression Regulation, Neoplastic
  • Genes, erbB*
  • Proto-Oncogene Proteins / biosynthesis
  • Receptor, ErbB-2 / biosynthesis
  • Receptor, ErbB-3
  • Receptors, Growth Factor / biosynthesis*
  • Retinoids / pharmacology*
  • Tretinoin / pharmacology

Substances

  • Antineoplastic Agents
  • Proto-Oncogene Proteins
  • Receptors, Growth Factor
  • Retinoids
  • Alitretinoin
  • Tretinoin
  • ErbB Receptors
  • Receptor, ErbB-2
  • Receptor, ErbB-3